BioAtla BCAB
OTC BCAB
$1.45 -0.05 (-3.33%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioAtla (BCAB) Net Margin (2020 - 2026)

Updated

BioAtla (BCAB) reported Net Margin of 6.95% for Q2 2026.

Analysis

BioAtla (BCAB) Net Margin (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BioAtla's Net Margin came in at -370.05%, up 171.00 percentage points year-over-year; for FY2025, it was -2980.35%, down 2346.02 percentage points from FY2024.

  • Net Margin has a five-year change of +5376.99 percentage points (FY2020 to FY2025).
  • By year, Net Margin came in at -634.33% in FY2024 and -38160.80% in FY2021 (-29803.46 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.83%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 21.27%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.30%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -134.51%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -1.65%
10 BioAtla 2.32 Mn -16.62 Mn - 6.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.95%
Dec 31, 2025 -489.20%
Sep 30, 2024 -96.24%
Jun 30, 2024 -2,341.33%
Jun 30, 2021 -12,152.40%
Sep 30, 2020 -7,754.67%
Jun 30, 2020 -3,274.74%
Mar 31, 2020 -1,802.25%
API Access

BioAtla Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY